{{ $ActivityName }}
Ovarian cancer
Breast cancer
Prostate cancer
Pancreatic cancer
Any Other
1st relapse
2nd relapse
Beyond 2nd relapse
HR +ve/HER2 -ve
TNBC
If any other
First line (In de-novo MBC)
Second line or late (Progressive MBC)
BRCA mutation (Tumor testing)
gBRCA mutation testing (Blood testing)
HRD
BRCA & HRD both
HRR Panel
Yes
No
Not known
As a monotherapy
In combination with
Complete response
Partial response
Stable disease
Not Assessed
Cash
Govt. Reimbursed
Insurance
State Yojna/ Ayushman Bharat Scheme